Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder

Carnero Contentti, Edgar; Correale, Jorge

dc.contributor.author	Carnero Contentti, Edgar
dc.contributor.author	Correale, Jorge
dc.date.accessioned	2025-03-20T16:39:44Z
dc.date.available	2025-03-20T16:39:44Z
dc.date.issued	2025-02-23
dc.identifier.citation	Carnero Contentti E, Correale J. Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder. Expert Opin Emerg Drugs. 23 de febrero de 2025	es_ES
dc.identifier.uri	https://doi.org/10.1080/14728214.2025.2470706
dc.identifier.uri	https://repositorio.fleni.org.ar/xmlui/handle/123456789/1328
dc.description.abstract	Resumen no disponible	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Taylor & Francis	es_ES
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Neuromyelitis Optica	es_ES
dc.subject	Neuromielitis Óptica	es_ES
dc.subject	Immune Tolerance	es_ES
dc.subject	Tolerancia Inmunológica	es_ES
dc.title	Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.type	info:eu-repo/semantics/publishedVersion
dc.description.fil	Fil: Correale, Jorge. Fleni. Departamento de Neurología. Servicio de Neuroinmunología y Enfermedades Desmielinizantes; Argentina.
dc.relation.ispartofCOUNTRY	Reino Unido
dc.relation.ispartofCITY	Oxford
dc.relation.ispartofTITLE	Expert Opinion on Emerging Drugs
dc.relation.ispartofISSN	1744-7623
dc.type.snrd	info:ar-repo/semantics/artículo	es_ES